# Brady Corp: Form 10-Q for the period ended Oct 31, 2020

- Company: [Brady Corp](/companies/brc.md) (CIK 746598)
- Form: 10-Q
- Filed: 2020-11-19
- Accepted by EDGAR: Nov 19, 2020, 07:11 ET
- Period: 2020-10-31
- Accession: 0000746598-20-000214
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/746598/000074659820000214/brc-20201031.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/746598/000074659820000214/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-10-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Cost of revenue | 3 months, 2020-08-01 to 2020-10-31 | $141.8m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2020-08-01 to 2020-10-31 | $135.4m | us-gaap:GrossProfit |
| Research and development | 3 months, 2020-08-01 to 2020-10-31 | $10.2m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2020-08-01 to 2020-10-31 | $83.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2020-08-01 to 2020-10-31 | $42.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2020-08-01 to 2020-10-31 | $106.0k | us-gaap:InterestExpense |
| Income tax | 3 months, 2020-08-01 to 2020-10-31 | $8.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2020-08-01 to 2020-10-31 | $33.5m | us-gaap:NetIncomeLoss |
| Diluted shares (weighted) | 3 months, 2020-08-01 to 2020-10-31 | 52,292,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2020-08-01 to 2020-10-31 | $62.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2020-08-01 to 2020-10-31 | $9.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2020-08-01 to 2020-10-31 | $11.4m | us-gaap:PaymentsOfDividends |
| Share repurchases | 3 months, 2020-08-01 to 2020-10-31 | $2.7m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2020-10-31 | $256.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2020-10-31 | $544.8m | us-gaap:AssetsCurrent |
| Total assets | at 2020-10-31 | $1.18bn | us-gaap:Assets |
| Current liabilities | at 2020-10-31 | $205.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2020-10-31 | $295.3m | us-gaap:Liabilities |
| Shareholders' equity | at 2020-10-31 | $880.4m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 27,135 characters.

#### Overview

Brady Corporation is a global manufacturer and supplier of identification solutions and workplace safety products that identify and protect premises, products and people. The IDS segment is primarily involved in the design, manufacture, and distribution of high-performance and innovative safety, identification and healthcare products. The WPS segment provides workplace safety, identification and compliance products, approximately half of which are internally manufactured and half of which are externally sourced.

The ability to provide customers with a broad range of proprietary, customized and diverse products for use in various applications across multiple industries and geographies, along with a commitment to quality and service, have made Brady a leader in many of its markets. The long-term sales growth and profitability of our segments will depend not only on improved demand in end markets and the overall economic environment, but also on our ability to continuously improve the efficiency of our global operations, deliver a high level of customer service, develop and market innovative new products, and to advance our digital capabilities. In our IDS business, our strategy for growth includes an increased focus on certain industries and products, a focus on improving the customer buying experience, and the development of technologically advanced, innovative and proprietary products. In our WPS business, our strategy for growth includes a focus on workplace safety critical industries, innovative new product offerings, compliance expertise, customization expertise, and improving our digital capabilities.

The following are key initiatives supporting our strategy in fiscal 2021:

- Investing in organic growth by enhancing our research and development process and utilizing customer feedback to develop innovative new products.
- Providing our customers with the highest level of customer service.
- Expanding and enhancing our sales capabilities through an improved digital presence and the use of data-driven marketing automation tools.
- Driving operational excellence and executing sustainable efficiency gains within our global operations and within our selling, general and administrative structures.
- Building on our culture of diversity and inclusion to increase employee engagement and enhance recruitment and retention practices.

#### Impact of the COVID-19 Pandemic on Our Business

The impact of the COVID-19 pandemic on the global economic environment has resulted in reduced demand across the majority of our end markets. In the near-term, the COVID-19 pandemic is expected to continue to have adverse effects on our sales, overall profitability, and cash provided by operating activities. As of the date of this filing, significant uncertainty exists concerning the magnitude of the impact and duration of the COVID-19 pandemic.

Brady Corporation is deemed an essential business under the majority of local government orders. Our products support first responders, healthcare workers, food processing companies, and many other critical industries. During the quarter ended October 31, 2020, our facilities were operating globally with enhanced safety protocols designed to protect the health and safety of our employees.

We have taken actions throughout our business to reduce controllable costs, including actions to reduce labor costs, eliminating non-essential travel, and reducing discretionary spend. We believe we have the financial strength to continue to invest in organic sales growth opportunities and research and development ("R&D"), while continuing to drive sustainable efficiencies and automation in our operations and selling, general and administrative expenses ("SG&A") functions. At October 31, 2020, we had cash of $256.3 million, an undrawn credit facility of $200 million, which can be increased up to $400 million at the Company's option and subject to certain conditions, and outstanding letters of credit of $3.5 million, for total available liquidity of approximately $653 million.

Due to the speed with which the COVID-19 pandemic developed and the resulting uncertainty, including the depth and duration of any disruptions to customers and suppliers, its future effect on our business, results of operations, and financial condition cannot be predicted. Despite this uncertainty, we believe that our financial resources, liquidity levels and debt-free status, along with various contingency plans to reduce costs are sufficient to manage the impact of the COVID-19 pandemic, which may result in reduced sales, reduced net income, and reduced cash provided by operating activities. Refer to Risk Factors, included in Part I, Item 1A of our Annual Report on Form 10-K for the year ended July 31, 2020, for further discussion of the possible impact of the COVID-19 pandemic on our business.

#### Results of Operations

A comparison of results of operating income for the three months ended October 31, 2020 and 2019 is as follows:

*(Dollars in thousands)*

|  | Three months ended October 31, 2020 | % Sales | 2019 | % Sales |
| --- | ---: | ---: | ---: | ---: |
| **Net sales** | $277,227 |  | $286,947 |  |
| **Gross margin** | 135,428 | 48.9% | 141,405 | 49.3% |
| **Operating expenses:** |  |  |  |  |
| Research and development | 10,203 | 3.7% | 10,967 | 3.8% |
| Selling, general and administrative | 83,037 | 30.0% | 89,547 | 31.2% |
| Total operating expenses | 93,240 | 33.6% | 100,514 | 35.0% |
| **Operating income** | $42,188 | 15.2% | $40,891 | 14.3% |

References in this Form 10-Q to “organic sales” refer to sales calculated in accordance with GAAP, excluding the impact of foreign currency translation. The Company's organic sales disclosures exclude the effects of foreign currency translation as foreign currency translation is subject to volatility that can obscure underlying business trends. Management believes that the non-GAAP financial measure of organic sales is meaningful to investors as it provides them with useful information to aid in identifying underlying sales trends in our businesses and facilitating comparisons of our sales performance with prior periods.

Net sales for the three months ended October 31, 2020, decreased 3.4% to $277.2 million, compared to $286.9 million in the same period in the prior year. The decrease consisted of an organic sales decline of 4.9% and an increase from foreign currency translation of 1.5%. Organic sales declined 8.4% in the IDS segment and grew 5.5% in the WPS segment during the three months ended October 31, 2020, compared to the same period in the prior year.

The COVID-19 pandemic had a significant impact on organic sales during the three months ended October 31, 2020, with the impact varying between the IDS and WPS segments. The IDS segment realized reduced demand across all major product lines, while the WPS segment realized increased demand globally for personal protective equipment and other pandemic-related safety and identification products during this same period.

Gross margin for the three months ended October 31, 2020, decreased 4.2% to $135.4 million, compared to $141.4 million in the same period in the prior year. As a percentage of net sales, gross margin decreased to 48.9% for the three months ended October 31, 2020, from 49.3% in the same period in the prior year. The decrease in gross margin as a percentage of net sales was primarily due to the decline in sales volumes in the IDS segment resulting from the economic slowdown caused by the COVID-19 pandemic as well as product mix in our WPS segment, which was partially mitigated by our ongoing efforts to streamline manufacturing processes and drive sustainable operational efficiencies.

R&D expenses for the three months ended October 31, 2020, declined 7.0% to $10.2 million, compared to $11.0 million in the same period in the prior year. As a percentage of sales, R&D expenses declined slightly to 3.7% for the three months ended October 31, 2020, compared to 3.8% in the same period in the prior year. The decrease in R&D spending was due to a decrease in headcount, improved efficiency, and the timing of expenditures related to ongoing new product development costs compared to the same period in the prior year. The Company remains committed to investing in new product development to increase sales within our IDS and WPS businesses. Investments in new printers and materials continue to be the primary focus of R&D expenditures.

SG&A expenses include selling and administrative costs directly attributed to the IDS and WPS segments, as well as certain other corporate administrative expenses including finance, information technology, human resources, and other administrative expenses. SG&A expenses declined 7.3% to $83.0 million for the three months ended October 31, 2020, compared to $89.5 million in the same period in the prior year. As a percentage of sales, SG&A was 30.0% for the three months ended October 31, 2020, compared to 31.2% in the same period in the prior year. The decrease in both SG&A expenses and SG&A expenses as a percentage of net sales from the same period of the prior year was primarily due to ongoing efficiency gains, a reduction in the SG&A cost structure, along with a reduction in discretionary spend, including travel for our sales people, which was partially offset by the impact of foreign currency translation.

Operating income increased 3.2% to $42.2 million for three months ended October 31, 2020, compared to $40.9 million in the same period in the prior year. The increase in operating income was primarily due to increased segment profit in the WPS segment as a result of organic sales growth as well as a reduction in the SG&A cost structure in both segments.

### OPERATING INCOME TO NET INCOME

*(Dollars in thousands)*

|  | Three months ended October 31, 2020 | % Sales | 2019 | % Sales |
| --- | ---: | ---: | ---: | ---: |
| Operating income | $42,188 | 15.2% | $40,891 | 14.3% |
| Other income (expense): |  |  |  |  |
| Investment and other income | 155 | 0.1% | 1,380 | 0.5% |
| Interest expense | (106) | —% | (701) | (0.2)% |
| Income before income tax and losses of unconsolidated affiliate | 42,237 | 15.2% | 41,570 | 14.5% |
| Income tax expense | 8,582 | 3.1% | 4,072 | 1.4% |
| Income before losses of unconsolidated affiliate | 33,655 | 12.1% | 37,498 | 13.1% |
| Equity in losses of unconsolidated affiliate | (174) | (0.1)% | — | —% |
| Net income | $33,481 | 12.1% | $37,498 | 13.1% |

Investment and other income was $0.2 million for the three months ended October 31, 2020, compared to $1.4 million for the same period in the prior year. The decrease was primarily due to reduced interest income as a result of the decline in interest rates.

Interest expense decreased to $0.1 million for the three months ended October 31, 2020, compared to $0.7 million for the same period in the prior year. The decrease in interest expense was due to the repayment of the Company's remaining principal balance under its private placement debt agreement during the fourth quarter of the fiscal year ended July 31, 2020.

The Company’s income tax rate was 20.3% for the three months ended October 31, 2020, compared to 9.8% in the same period in the prior year. Refer to Note M "Income Taxes" for additional information on the Company's effective income tax rate.

Equity in losses of unconsolidated affiliate of $0.2 million for the three months ended October 31, 2020 represented the Company's proportionate share of the loss in its equity interest in React Mobile, Inc., an employee safety software and hardware company based in the United States.

#### Business Segment Operating Results

The Company evaluates short-term segment performance based on segment profit and customer sales. Interest expense, investment and other income, income tax expense, equity in losses of unconsolidated affiliate, and certain corporate administrative expenses are excluded when evaluating segment performance.

The following is a summary of segment information for the three months ended October 31, 2020 and 2019:

| SALES GROWTH INFORMATION ID Solutions | Three months ended October 31, 2020 | 2019 |
| --- | ---: | ---: |
| Organic | (8.4)% | (0.2)% |
| Currency | 0.6% | (1.2)% |
| Total | (7.8)% | (1.4)% |
| **Workplace Safety** |  |  |
| Organic | 5.5% | (0.8)% |
| Currency | 4.3% | (3.4)% |
| Total | 9.8% | (4.2)% |
| **Total Company** |  |  |
| Organic | (4.9)% | (0.4)% |
| Currency | 1.5% | (1.7)% |
| Total | (3.4)% | (2.1)% |
| **SEGMENT PROFIT AS A PERCENT OF NET SALES** |  |  |
| ID Solutions | 20.3% | 19.7% |
| Workplace Safety | 10.1% | 7.2% |
| Total | 17.4% | 16.6% |

19

### ID Solutions

IDS net sales decreased 7.8% for the three months ended October 31, 2020, compared to the same period in the prior year, which consisted of an organic sales decline of 8.4% and an increase from foreign currency translation of 0.6%. The economic slowdown caused by the COVID-19 pandemic had a significant impact on organic sales during the quarter, which resulted in organic sales declines across all major product lines for the three months ended October 31, 2020.

Organic sales in the Americas declined in the high-single digits for the three months ended October 31, 2020, compared to the same period in the prior year. Organic sales declined across all major product lines due to the economic slowdown caused by the COVID-19 pandemic. Organic sales declined by approximately 10% in the United States and declined in the low-single digits in remainder of the Americas region.

Organic sales in Europe declined in the mid-single digits for the three months ended October 31, 2020, as compared to the same period in the prior year. Organic sales declined across all major product lines due to the economic slowdown caused by the COVID-19 pandemic. The organic sales decline was broad-based throughout Western Europe, which was partially offset by mid-single digit organic sales growth for certain businesses based in emerging geographies.

Organic sales in Asia declined in the low-single digits for the three months ended October 31, 2020, as compared to the same period in the prior year. Organic sales growth in the safety and facility identification and wire identification product lines was offset by an organic sales decline in the product identification product line. The low-single digit decline was broad-based throughout Asia.

Segment profit decreased 5.1% to $40.3 million for the three months ended October 31, 2020, compared to $42.4 million in the same period in the prior year. As a percentage of net sales, segment profit was 20.3% for the three months ended October 31, 2020, compared to 19.7% in the same period in the prior year. The increase in segment profit as a percentage of sales was primarily driven by the reduced cost structure throughout the IDS segment and a reduction in discretionary spending in response to the decline in revenue from the impact of the COVID-19 pandemic.

### Workplace Safety

WPS net sales increased 9.8% for the three months ended October 31, 2020, compared to the same period in the prior year, which consisted of organic sales growth of 5.5% and an increase from foreign currency translation of 4.3%. Sales through the digital channel increased in the mid-teens and sales through the traditional catalog channel increased in the low-single digits. The WPS business realized increased demand globally for personal protective equipment, social distancing signage and floor markings, and other COVID-19 pandemic-related products.

Organic sales in Europe increased in the high-single digits for the three months ended October 31, 2020, compared to the same period in the prior year. Sales through the digital channel increased in the mid-teens, which was driven by digital marketing campaigns emphasizing personal protective equipment and other COVID-19 pandemic-related products. Sales through the traditional catalog channel increased in the mid-single digits. Organic sales growth in Europe was led by businesses in France followed by growth in Norway and the U.K., which was partially offset by a decline in organic sales in Germany.

Organic sales in North America declined in the low-single digits for the three months ended October 31, 2020, compared to the same period in the prior year. This decrease was driven by a low-single digit decline in traditional catalog sales, which was partially offset by low-single digit growth in sales through the digital channel. The increase in digital sales was primarily due to increased sales of personal protective equipment, social distancing signage and floor markings, and other COVID-19 pandemic-related products.

Organic sales in Australia increased just over 10% for the three months ended October 31, 2020, compared to the same period of the prior year. Digital channel sales grew approximately 40% over the same period in the prior year, which was driven by digital marketing campaigns emphasizing personal protective equipment along with floor markings and signage related to social distancing and personal hygiene. Sales through the traditional catalog channel increased in the mid-single digits. Our Australian business generated increased sales in a variety of product categories related to mitigating the COVID-19 pandemic, including various types of personal protective equipment and other healthcare supplies.

Segment profit increased to $8.0 million for the three months ended October 31, 2020, compared to $5.2 million in the same period of the prior year. As a percentage of net sales, segment profit increased to 10.1% for the three months ended October 31, 2020, compared to 7.2% in the same period of the prior year. The increase in segment profit was primarily driven by increased organic sales volumes combined with the reduced SG&A cost structure, and to a lesser extent foreign currency translation.

#### Liquidity and Capital Resources

The Company's cash balances are generated and held in numerous locations throughout the world. At October 31, 2020, approximately 66% of the Company's cash and cash equivalents were held outside the United States. The Company's growth has historically been funded by a combination of cash provided by operating activities and debt financing. The Company believes that its cash flow from operating activities and its borrowing capacity are sufficient to fund its anticipated requirements for working capital, capital expenditures, research and development, common stock repurchases, and dividend payments for the next 12 months. Although the Company believes these sources of cash are currently sufficient to fund domestic operations, annual cash needs could require repatriation of cash to the U.S. from foreign jurisdictions, which may result in additional tax payments.

#### Cash Flows

Cash and cash equivalents were $256.3 million at October 31, 2020, an increase of $38.7 million from July 31, 2020. The significant changes were as follows:

*(Dollars in thousands)*

| Net cash flow provided by (used in): | Three months ended October 31, 2020 | 2019 |
| --- | ---: | ---: |
| Operating activities | $62,838 | $38,848 |
| Investing activities | (9,202) | (7,197) |
| Financing activities | (16,551) | (15,326) |
| Effect of exchange rate changes on cash | 1,605 | (304) |
| Net increase in cash and cash equivalents | $38,690 | $16,021 |

Net cash provided by operating activities was $62.8 million for the three months ended October 31, 2020, compared to $38.8 million in the same period of the prior year. The increase was primarily due to an increase in cash provided by working capital. Inventory levels were reduced which resulted in the majority of the increase in cash provided by operating activities, which was due to a planned reduction in inventory following a period of increased balances to reduce the risk of supply chain disruption resulting from the COVID-19 pandemic. In addition, the timing of accounts payable and other compensation-related withholding increased cash provided by working capital, which was partially offset by a decrease in cash provided by accounts receivable due to increasing sequential sales during the quarter.

Net cash used in investing activities was $9.2 million for the three months ended October 31, 2020, compared to $7.2 million used in the same period of the prior year. The increase in cash used in investing activities was primarily driven by an increase in capital expenditures for the purchase of facility upgrades and manufacturing equipment in Europe, the United States, and Mexico.

Net cash used in financing activities was $16.6 million during the three months ended October 31, 2020, compared to $15.3 million used in the same period of the prior year. The increase in cash used in financing activities was primarily driven by $2.7 million of share repurchases and a decrease in cash proceeds from the exercise of stock options, which was largely offset by a decrease in cash payments for employee taxes withheld from stock-based awards.

#### Credit Facilities

On August 1, 2019, the Company and certain of its subsidiaries entered into an unsecured $200 million multi-currency revolving loan agreement with a group of five banks that replaced and terminated the Company’s previous loan agreement that had been entered into on September 25, 2015. Under the new revolving loan agreement, the Company has the option to select either a Eurocurrency rate loan that bears interest at the LIBOR rate plus a margin based on the Company's consolidated net leverage ratio or a base interest rate (based upon the higher of the federal funds rate plus 0.5%, the prime rate of the Bank of Montreal plus a margin based on the Company’s consolidated net leverage ratio, or the Eurocurrency base rate at the LIBOR rate plus a margin based on the Company’s consolidated net leverage ratio plus 1%). At the Company's option, and subject to certain conditions, the available amount under the revolving loan agreement may be increased from $200 million to $400 million. The maximum amount outstanding on the Company's revolving loan agreement during the three months ended October 31, 2020 was $10.6 million. As of October 31, 2020, there were no borrowings outstanding on the credit facility. The Company had letters of credit outstanding under the loan agreement of $3.5 million as of October 31, 2020 and there was $196.5 million available for future borrowing, which can be increased to $396.5 million at the Company's option, subject to certain conditions. The revolving loan agreement has a final maturity date of August 1, 2024, as such, any borrowing would be classified as long-term on the accompanying condensed consolidated balance sheets.

#### Covenant Compliance

The Company's revolving loan agreement requires it to maintain certain financial covenants, including a ratio of debt to the trailing twelve months EBITDA, as defined in the debt agreements, of not more than a 3.5 to 1.0 ratio (leverage ratio) and the trailing twelve months EBITDA to interest expense of not less than a 3.0 to 1.0 ratio (interest expense coverage). As of October 31, 2020, the Company was in compliance with these financial covenants.

#### Off-Balance Sheet Arrangements

The Company does not have material off-balance sheet arrangements. The Company is not aware of factors that are reasonably likely to adversely affect liquidity trends, other than the risk factors described in this and other Company filings. However, the following additional information is provided to assist those reviewing the Company’s financial statements.

Purchase Commitments - The Company has purchase commitments for materials, supplies, services, and property, plant and equipment as part of the ordinary conduct of its business. In the aggregate, such commitments are not in excess of current market prices and are not material to the financial position of the Company. Due to the proprietary nature of many of the Company’s materials and processes, certain supply contracts contain penalty provisions for early termination. The Company does not believe a material amount of penalties will be incurred under these contracts based upon historical experience and current expectations.

Other Contractual Obligations - The Company does not have material financial guarantees or other contractual commitments that are reasonably likely to adversely affect liquidity.

#### Forward-Looking Statements

In this quarterly report on Form 10-Q, statements that are not reported financial results or other historic information are “forward-looking statements.” These forward-looking statements relate to, among other things, the Company's future financial position, business strategy, targets, projected sales, costs, income, capital expenditures, debt levels and cash flows, and plans and objectives of management for future operations.

The use of words such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “should,” “project” or “plan” or similar terminology are generally intended to identify forward-looking statements. These forward-looking statements by their nature address matters that are, to different degrees, uncertain and are subject to risks, assumptions, and other factors, some of which are beyond Brady's control, that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. For Brady, uncertainties arise from:

- Adverse impacts of the novel coronavirus ("COVID-19") pandemic or other pandemics
- Decreased demand for the Company's products
- Ability to compete effectively or to successfully execute its strategy
- Ability to develop technologically advanced products that meet customer demands
- Raw material and other cost increases
- Difficulties in protecting websites, networks, and systems against security breaches
- Extensive regulations by U.S. and non-U.S. governmental and self-regulatory entities
- Risks associated with the loss of key employees
- Divestitures, contingent liabilities from divestitures and the failure to identify, integrate, and grow acquired companies
- Litigation, including product liability claims
- Foreign currency fluctuations
- Potential write-offs of goodwill and other intangible assets
- Changes in tax legislation and tax rates
- Differing interests of voting and non-voting shareholders
- Numerous other matters of national, regional and global scale, including major public health crises and government responses thereto and those of a political, economic, business, competitive, and regulatory nature contained from time to time in Brady's U.S. Securities and Exchange Commission filings, including, but not limited to, those factors listed in the “Risk Factors” section within Item 1A of Part I of Brady's Form 10-K for the year ended July 31, 2020.

These uncertainties may cause Brady's actual future results to be materially different than those expressed in its forward-looking statements. Brady does not undertake to update its forward-looking statements except as required by law.

## Market risk

As filed, 158 characters.

Refer to the Company’s annual report on Form 10-K for the year ended July 31, 2020. There has been no material change in this information since July 31, 2020.

## Controls and procedures

As filed, 1,802 characters.

Brady Corporation maintains a set of disclosure controls and procedures that are designed to ensure that information required to be disclosed by the Company in the reports filed by the Company under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports the Company files under the Exchange Act is accumulated and communicated to the Company’s management, including the Company’s principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. The Company carried out an evaluation, under the supervision and with the participation of its management, including its President and Chief Executive Officer and its Chief Financial Officer and Treasurer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Rule 13a-15 of the Exchange Act. Based on that evaluation, the Company’s President & Chief Executive Officer and Chief Financial Officer and Treasurer concluded that the Company’s disclosure controls and procedures are effective as of the end of the period covered by this report.

There were no changes in the Company's internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) that occurred during the Company's most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

## Risk factors

As filed, 3,917 characters.

The Company’s business, results of operations, financial condition, and cash flows are subject to various risks and uncertainties, including those described in Part I, Item 1A, “Risk Factors” of Brady's Annual Report on Form 10-K for the year ended July 31, 2020. Other than as set forth below, there have been no material changes from the risk factors set forth in the 2020 Form 10-K.

***Our results of operations have been and will in the future be adversely impacted by the COVID-19 pandemic or other pandemics, and the duration and extent to which it will impact our business and financial results remains uncertain.***

The global spread of COVID-19 has resulted in significant economic disruption, has negatively impacted our financial results, and significantly increased future uncertainty. The extent to which the COVID-19 pandemic will continue to impact our business, results of operations, and financial condition will depend on numerous evolving factors and future developments, which are highly uncertain and cannot be predicted at this time. Such factors and developments may include the geographic spread, severity and duration of the COVID-19 pandemic, including whether there are periods of increased COVID-19 cases, disruption to our operations resulting from employee illnesses, the development and availability of effective treatment or vaccines, the extent and duration of the impact on the U.S. or global economy, including the pace and extent of recovery when the pandemic subsides, and the actions that have been and may be taken by various governmental authorities in response to the outbreak, including mandatory facility closures of non-essential businesses, stay-at-home orders, or similar restrictions, all of which may continue to effect our customers and customers' demand for our services and products, reduce demand for healthcare services, impact our suppliers or cause disruptions in the global supply chain, and impact our ability to sell and manufacture our products. Certain jurisdictions have begun lifting stay-at-home orders only to impose further restrictions in the wake of increases in new COVID-19 cases. As such, there is considerable uncertainty regarding how current and future health and safety measures implemented in response to the COVID-19 pandemic will impact our business. In addition, the deterioration of macroeconomic conditions may impact the proper functioning of financial and capital markets, foreign currency exchange rates, commodity and energy prices, and interest rates. Even after the COVID-19 pandemic subsides, we may continue to experience adverse impacts to our business and financial results due to any economic recession or depression that has occurred, and due to any major public health crises that may occur in the future.

Although our current accounting estimates contemplate current and expected future conditions, as applicable, it is reasonably possible that actual conditions could differ from our expectations, which could materially affect our results of operations and financial position. In particular, a number of estimates have been and will continue to be affected by the ongoing COVID-19 pandemic. The severity, magnitude and duration, as well as the economic consequences of the COVID-19 pandemic, are uncertain, rapidly changing and difficult to predict. As a result, our accounting estimates and assumptions may change over time in response to COVID-19. Such changes could result in future impairments of goodwill, intangible assets, long-lived assets, incremental credit losses on accounts receivable, excess and obsolete inventory, or a decrease in the carrying amount of our deferred tax assets. Any of these events could amplify the other risks and uncertainties described in our Annual Report on Form 10-K for the fiscal year ended July 31, 2020 and could have an adverse effect on our business and financial results.

Filed Nov 19, 2020.
Source: SEC EDGAR, the filing index for accession 0000746598-20-000214. Last ingested by Listed: Nov 9, 2026, 17:29 ET. No prices; not investment advice.
